Peptide conjugation to enhance oligonucleotide delivery

Peptide conjugation to enhance oligonucleotide delivery

Thesis: Ph. D. in Biological Chemistry, Massachusetts Institute of Technology, Department of Chemistry, 2018.

Bibliographic Details
Main Author:	Wolfe, Justin Mahoney
Other Authors:	Bradley L. Pentelute.
Format:	Thesis
Language:	eng
Published:	Massachusetts Institute of Technology 2018
Subjects:	Chemistry.
Online Access:	http://hdl.handle.net/1721.1/118278

Similar Items

Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides
by: Wolfe, Justin, et al.
Published: (2020)

Peptide-mediated delivery of antisense oligonucleotides and chemotherapeutics across biological barriers
by: Fadzen, Colin MacLaine
Published: (2018)

Peptide–Oligonucleotide Conjugation: Chemistry and Therapeutic Applications
by: Anna L. Malinowska, et al.
Published: (2024-09-01)

Chemistry of Peptide-Oligonucleotide Conjugates: A Review
by: Kristina Klabenkova, et al.
Published: (2021-09-01)

Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies
by: Saeed Anwar, et al.
Published: (2023-04-01)

Cell-penetrating peptides to enhance delivery of Oligonucleotide-based therapeutics
by: McClorey, G, et al.
Published: (2018)

Optimizing tissue-specific antisense oligonucleotide-peptide conjugates.
by: Betts, C, et al.
Published: (2012)

Protocol to generate, purify, and analyze antibody-oligonucleotide conjugates from off-the-shelf antibodies
by: Tony Rady, et al.
Published: (2024-12-01)

A modular approach to enzymatic ligation of peptides and proteins with oligonucleotides
by: Tan, Derrick Jing Yang, et al.
Published: (2022)

Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
by: Phuc Tran, et al.
Published: (2022-02-01)

Ruthenium mimics of [Fe]-hydrogenase: synthesis, reactivity and peptide conjugation
by: Wong, Zhen Xuan
Published: (2023)

Conjugation of Duplexed siRNN Oligonucleotides with DD-HyNic Peptides for Cellular Delivery of RNAi Triggers
by: Alexander Hamil, et al.
Published: (2016-04-01)

Strategies for combinatorial development of siRNA conjugate delivery systems
by: Kanasty, Rosemary L
Published: (2015)

Coupling Strategies for the Synthesis of Peptide-Oligonucleotide Conjugates for Patterned Synthetic Biomineralization
by: Joshua D. Carter, et al.
Published: (2011-01-01)

Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA
by: Jamie Leckie, et al.
Published: (2024-06-01)

Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
by: Haneen Daralnakhla, et al.
Published: (2021-01-01)

Cationic oligonucleotide derivatives and conjugates: A favorable approach for enhanced DNA and RNA targeting oligonucleotides
by: Mathias B. Danielsen, et al.
Published: (2021-07-01)

Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease
by: André D.G. Leitão, et al.
Published: (2023-10-01)

Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles
by: Kamil Bakowski, et al.
Published: (2022-12-01)

Synthesis of Protein-Oligonucleotide Conjugates
by: Emma E. Watson, et al.
Published: (2022-10-01)

Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads
by: Dhar, Shanta, et al.
Published: (2013)

Sustained delivery of a novel natriuretic peptide for three weeks with in situ polymer precipitation delivery system
by: Lim, Soo G., et al.
Published: (2013)

Delivery of RNAi-Based Oligonucleotides by Electropermeabilization
by: Muriel Golzio, et al.
Published: (2013-04-01)

Peptide-mediated cell and in vivo delivery of antisense oligonucleotides and siRNA
by: Järver, P, et al.
Published: (2012)

Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
by: Peter Järver, et al.
Published: (2012-01-01)

Peptide Conjugation via CuAAC ‘Click’ Chemistry
by: Istvan Toth, et al.
Published: (2013-10-01)

Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide
by: Umme Sabrina Haque, et al.
Published: (2023-10-01)

Antibody-oligonucleotide conjugate achieves CNS delivery in animal models for spinal muscular atrophy
by: Suzan M. Hammond, et al.
Published: (2022-12-01)

Design and synthesis of modified deoxynucleosides, site specifically damaged oligonucleotides, and repair inhibiting chemotherapeutic agents
by: Morningstar, Marshall Lee
Published: (2005)

Immortalized canine dystrophic myoblast cell lines for development of peptide-conjugated splice-switching oligonucleotides
by: Tone, Y, et al.
Published: (2021)

Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies
by: Carme Fàbrega, et al.
Published: (2023-01-01)

Peptide–oligonucleotide conjugates as nanoscale building blocks for assembly of an artificial three-helix protein mimic
by: Chenguang Lou, et al.
Published: (2016-07-01)

Oligonucleotide-Peptide Conjugates: Solid-Phase Synthesis under Acidic Conditions and Use in ELISA Assays
by: Ramon Eritja, et al.
Published: (2012-11-01)

Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer
by: Amanee D Salaam, et al.
Published: (2014-07-01)

Enhancing peptide and PMO delivery to mouse airway epithelia by chemical conjugation with the amphiphilic peptide S10
by: Maud Auger, et al.
Published: (2024-09-01)

Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
by: Andaloussi, S, et al.
Published: (2011)

Development of topoisomerase I inhibitors on the basis of structural variation of oligonucleotides.
by: Quek, Ngee Mien.
Published: (2011)

Biophysical studies of oligonucleotides containing duplex stabilising modifications
by: Marafini, P
Published: (2016)

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice
by: Klein, AF, et al.
Published: (2019)

Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.
by: Yin, H, et al.
Published: (2008)